Triple

T184500
Position Surface form Disambiguated ID Type / Status
Subject European Medicines Agency E3950 entity
Predicate hasCommittee P1396 FINISHED
Object Committee for Medicinal Products for Human Use E23504 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Committee for Medicinal Products for Human Use | Statement: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Human Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Committee for Medicinal Products for Human Use
Context triple: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Human Use]
  • A. Committee for Proprietary Medicinal Products chosen
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • C. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • D. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • E. UK Medicines and Healthcare products Regulatory Agency
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a25497e2f08190a040f8c6e1842643 completed Feb. 28, 2026, 2:36 a.m.
NER Named-entity recognition batch_69a25926be9c8190a4cfce66f57589d1 completed Feb. 28, 2026, 2:55 a.m.
NED1 Entity disambiguation (via context triple) batch_69a305e511a08190a560125ed3839a0c completed Feb. 28, 2026, 3:12 p.m.
Created at: Feb. 28, 2026, 2:40 a.m.